[1] 肖贵宝.不同年龄和血清HBV DNA水平慢性乙型肝炎患者肝组织病理学变化.实用肝脏病杂志,2018,21:277-278.
[2] 胡小娟,刘锦萍,吕志红,等.肝脏和脾脏VTQ值对慢性乙型肝炎患者肝纤维化的诊断效能研究.实用肝脏病杂志,2018,21:459-460.
[3] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).肝脏,2015,20:915-932.
[4] Fukuo Y, Yamashina S, Sonoue H, et al. Abnormality of autophagic function and cathepsin expression in the liver from patients with non‐alcoholic fatty liver disease. Hepatol Res, 2014, 44:1026-1036.
[5] Verdelho MM. Controlled attenuation parameter as a noninvasive method to detect and quantify hepatic steatosis in chronic liver disease: What is the clinical relevance. GE Port J Gastroenterol, 2017, 24:157-160.
[6] Pais R, Rusu E, Zilisteanu D, et al. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. Eur J Intern Med, 2015, 26:30-36.
[7] Borja MS, Ng KF,Irwin A,et al. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res,2015,56:2002-2009.
[8] Zafar TA,Al-Hassawi F, Al-Khulaifi F,et al. Organoleptic and glycemic properties of chickpea-wheat composite breads. J Food Sci Technol,2015,52:2256-2263.
[9] 刘瑜,侯淑娅,王文豪,等.慢性乙型肝炎患者糖代谢水平对肝脏炎症及纤维化的影响.临床心身疾病杂志,2018,24:14-16,34
[10] Li JS, Wang WJ,Sun Y,et al. Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress. Food Funct,2015,6:1643-1651. |
